Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer
By Mary Chris Jaklevic,
Health News Review
| 10. 13. 2016
Genetic testing for breast and ovarian cancer risk is cheaper and easier than ever. But just because a test is available doesn’t mean everyone should get it.
That message didn’t come through in a recent series of patient anecdotes published on Women’s Health magazine’s web site:
Each of these stories featured a healthy young woman who decided to undergo testing for mutations associated with increased risk of breast and ovarian cancer. Two of the women had family histories of cancer that spurred their decisions, but the third had no known risk factors and was simply “curious” to learn about her genetics.
Because insurance wouldn’t pay for her test, the woman with a clean history paid $249 to Color Genomics for a test kit. “We all have access to this technology now...
Related Articles
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...